Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors
Abstract Aims The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet‐rich fibrin (PRF) and bovine bone substitute. Materials...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Clinical and Experimental Dental Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/cre2.263 |
id |
doaj-d43f569e9105487b9e1952e6700ee689 |
---|---|
record_format |
Article |
spelling |
doaj-d43f569e9105487b9e1952e6700ee6892020-11-25T03:23:45ZengWileyClinical and Experimental Dental Research2057-43472020-04-016223624310.1002/cre2.263Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factorsJoost E.I.G. Brouwers0Lisa N. van derVorm1Sharon Buis2Rianne Haumann3Avesta Karanzai4Joke Konings5Philip G. deGroot6Bas deLaat7Jasper A. Remijn8Institute for Dental Implantology Amersfoort The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsInstitute for Dental Implantology Amersfoort The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsInstitute for Dental Implantology Amersfoort The NetherlandsSynapse Research Institute Maastricht The NetherlandsSynapse Research Institute Maastricht The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsDepartment of Clinical Chemistry and Hematology Gelre Hospitals Apeldoorn The NetherlandsAbstract Aims The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet‐rich fibrin (PRF) and bovine bone substitute. Materials and methods Fifty patients were included between 2015 and 2017. PRF was prepared from autologous blood, in which blood cells and coagulation factor levels were measured. PRF and bovine bone were placed in the socket, followed by closure with PRF membrane. Implants were placed 14 (±2.5) weeks postextraction. The implant stability quotient was measured at t = 0, t = 10 days, t = 7 weeks, and t = 17 weeks by resonance frequency analysis. Results Erythrocyte count was inversely associated with PRF membrane length, but not with implant stability. Conversely, platelet count did not correlate with membrane size but inversely correlated with implant stability at 7 and 17 weeks. In addition, implant stability was directly correlated with levels FXIII (t = 0, p < .01), active von Willebrand factor (VWF; t = 0 and 7 weeks, p < .05), and total VWF (t = 7 weeks, p = .012). Conclusion Implant stability following alveolar ridge preservation with PRF and bovine bone substitute is associated with circulating blood cells and coagulation factors. In particular, fibrin structure, VWF, and FXIII may be important modulators of implant stability.https://doi.org/10.1002/cre2.263alveolar ridge preservationblood cellsblood coagulationimplant stabilityplatelet‐rich fibrin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joost E.I.G. Brouwers Lisa N. van derVorm Sharon Buis Rianne Haumann Avesta Karanzai Joke Konings Philip G. deGroot Bas deLaat Jasper A. Remijn |
spellingShingle |
Joost E.I.G. Brouwers Lisa N. van derVorm Sharon Buis Rianne Haumann Avesta Karanzai Joke Konings Philip G. deGroot Bas deLaat Jasper A. Remijn Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors Clinical and Experimental Dental Research alveolar ridge preservation blood cells blood coagulation implant stability platelet‐rich fibrin |
author_facet |
Joost E.I.G. Brouwers Lisa N. van derVorm Sharon Buis Rianne Haumann Avesta Karanzai Joke Konings Philip G. deGroot Bas deLaat Jasper A. Remijn |
author_sort |
Joost E.I.G. Brouwers |
title |
Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
title_short |
Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
title_full |
Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
title_fullStr |
Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
title_full_unstemmed |
Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
title_sort |
implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
publisher |
Wiley |
series |
Clinical and Experimental Dental Research |
issn |
2057-4347 |
publishDate |
2020-04-01 |
description |
Abstract Aims The aim of the present study was to assess the association between dental implant stability and peripheral blood cell composition and levels of coagulation factors in patients treated with alveolar ridge preservation with platelet‐rich fibrin (PRF) and bovine bone substitute. Materials and methods Fifty patients were included between 2015 and 2017. PRF was prepared from autologous blood, in which blood cells and coagulation factor levels were measured. PRF and bovine bone were placed in the socket, followed by closure with PRF membrane. Implants were placed 14 (±2.5) weeks postextraction. The implant stability quotient was measured at t = 0, t = 10 days, t = 7 weeks, and t = 17 weeks by resonance frequency analysis. Results Erythrocyte count was inversely associated with PRF membrane length, but not with implant stability. Conversely, platelet count did not correlate with membrane size but inversely correlated with implant stability at 7 and 17 weeks. In addition, implant stability was directly correlated with levels FXIII (t = 0, p < .01), active von Willebrand factor (VWF; t = 0 and 7 weeks, p < .05), and total VWF (t = 7 weeks, p = .012). Conclusion Implant stability following alveolar ridge preservation with PRF and bovine bone substitute is associated with circulating blood cells and coagulation factors. In particular, fibrin structure, VWF, and FXIII may be important modulators of implant stability. |
topic |
alveolar ridge preservation blood cells blood coagulation implant stability platelet‐rich fibrin |
url |
https://doi.org/10.1002/cre2.263 |
work_keys_str_mv |
AT joosteigbrouwers implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT lisanvandervorm implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT sharonbuis implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT riannehaumann implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT avestakaranzai implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT jokekonings implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT philipgdegroot implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT basdelaat implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors AT jasperaremijn implantstabilityinpatientstreatedwithplateletrichfibrinandbovinebonesubstituteforalveolarridgepreservationisassociatedwithperipheralbloodcellsandcoagulationfactors |
_version_ |
1724604719483060224 |